Cargando…

Breast Cancer Disparities and the COVID-19 Pandemic

PURPOSE OF REVIEW: The COVID-19 pandemic has placed unprecedented challenges on breast cancer patients and health care providers. The impact of the pandemic on preexisting breast cancer disparities remains unknown but is projected to have adverse outcomes. RECENT FINDINGS: Early work has demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasano, Genevieve A., Bayard, Solange, Bea, Vivian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425818/
https://www.ncbi.nlm.nih.gov/pubmed/36059579
http://dx.doi.org/10.1007/s12609-022-00458-y
_version_ 1784778547655606272
author Fasano, Genevieve A.
Bayard, Solange
Bea, Vivian J.
author_facet Fasano, Genevieve A.
Bayard, Solange
Bea, Vivian J.
author_sort Fasano, Genevieve A.
collection PubMed
description PURPOSE OF REVIEW: The COVID-19 pandemic has placed unprecedented challenges on breast cancer patients and health care providers. The impact of the pandemic on preexisting breast cancer disparities remains unknown but is projected to have adverse outcomes. RECENT FINDINGS: Early work has demonstrated that pandemic-related temporary suspensions in breast cancer screening, interruption of clinical trials, and treatment delays have an adverse impact on breast cancer patient outcomes and may worsen disparities. SUMMARY: In this review, we highlight existing knowledge regarding breast cancer disparities and the impact of the COVID-19 pandemic. Strategies for mitigating disparities moving forward include targeted research evaluating race-specific outcomes, targeted education for providers regarding breast health disparities, improved access to telehealth, maintenance of patient navigation programs, and patient education regarding the safety and necessity of enrollment in clinical trials.
format Online
Article
Text
id pubmed-9425818
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-94258182022-08-30 Breast Cancer Disparities and the COVID-19 Pandemic Fasano, Genevieve A. Bayard, Solange Bea, Vivian J. Curr Breast Cancer Rep Breast Cancer Disparities (LA Newman, Section Editor) PURPOSE OF REVIEW: The COVID-19 pandemic has placed unprecedented challenges on breast cancer patients and health care providers. The impact of the pandemic on preexisting breast cancer disparities remains unknown but is projected to have adverse outcomes. RECENT FINDINGS: Early work has demonstrated that pandemic-related temporary suspensions in breast cancer screening, interruption of clinical trials, and treatment delays have an adverse impact on breast cancer patient outcomes and may worsen disparities. SUMMARY: In this review, we highlight existing knowledge regarding breast cancer disparities and the impact of the COVID-19 pandemic. Strategies for mitigating disparities moving forward include targeted research evaluating race-specific outcomes, targeted education for providers regarding breast health disparities, improved access to telehealth, maintenance of patient navigation programs, and patient education regarding the safety and necessity of enrollment in clinical trials. Springer US 2022-08-30 2022 /pmc/articles/PMC9425818/ /pubmed/36059579 http://dx.doi.org/10.1007/s12609-022-00458-y Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Breast Cancer Disparities (LA Newman, Section Editor)
Fasano, Genevieve A.
Bayard, Solange
Bea, Vivian J.
Breast Cancer Disparities and the COVID-19 Pandemic
title Breast Cancer Disparities and the COVID-19 Pandemic
title_full Breast Cancer Disparities and the COVID-19 Pandemic
title_fullStr Breast Cancer Disparities and the COVID-19 Pandemic
title_full_unstemmed Breast Cancer Disparities and the COVID-19 Pandemic
title_short Breast Cancer Disparities and the COVID-19 Pandemic
title_sort breast cancer disparities and the covid-19 pandemic
topic Breast Cancer Disparities (LA Newman, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425818/
https://www.ncbi.nlm.nih.gov/pubmed/36059579
http://dx.doi.org/10.1007/s12609-022-00458-y
work_keys_str_mv AT fasanogenevievea breastcancerdisparitiesandthecovid19pandemic
AT bayardsolange breastcancerdisparitiesandthecovid19pandemic
AT beavivianj breastcancerdisparitiesandthecovid19pandemic